Akums Drugs and Pharmaceuticals Limited — Others, 29-03-2025: Trading Window

Akums has announced a board meeting to consider and approve the financial results for the quarter and half-year ending 31st March, 2025. The trading window for designated persons, including their immediate relatives, will be closed from 1st April, 2025, until 48 hours after the results are declared. This strategic move aligns with compliance protocols, ensuring proper governance in insider trading matters. For investors, the closure may generate a cautious sentiment, indicating a period of limited trading activity before significant financial disclosures, but it also reflects a commitment to transparency and regulatory adherence.